Gates Foundation Strategic Investment Fund Logo
Share this page:

Lilly mAb

The foundation partnered with Eli Lilly and Company to facilitate access to future Lilly therapeutic antibodies under development for the prevention and treatment of COVID-19 for low- and middle-income countries as part of the COVID-19 Therapeutics Accelerator. The COVID-19 antibodies will be manufactured at FUJIFILM Diosynth Biotechnologies facility in Denmark, where the Therapeutics Accelerator has reserved manufacturing capacity.

Investment Date: October 2020

Press Release